A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries

Table 1 Purchase trends for Indian generic, non-Indian generic and originator ARVs, 2003-2008

	2003	2004	2005	2006	2007	2008
# Countries reporting any ARV purchase	15	69	86	86	90	100
Indian generic ARVs
# manufacturers	4	8	6	7	9	10
# products/dosage forms	14	31	30	37	47	53
# purchases	62	740	1142	1273	2433	5906
# purchasing countries	11	55	70	78	81	96
NRTIs	11	53	66	74	80	92
NNRTIs	6	51	65	63	75	93
PIs	4	17	20	26	31	37
value (USD millions)	0.67	43.84	86.54	93.40	188.08	301.38
Non-Indian generic ARVs
# manufacturers	0	2	3	2	3	6
# products/dosage forms	0	5	19	15	18	15
# purchases	0	10	228	124	201	316
# purchasing countries	0	4	10	13	20	29
NRTIs	0	2	9	11	20	25
NNRTIs	0	2	4	3	6	5
PIs	0	0	1	0	0	0
value (USD millions)	0	0.12	27.38	3.72	14.34	58.76
Originator ARVs
# manufacturers	6	8	8	7	7	8
# products/dosage forms	18	32	33	39	40	39
# purchases	35	654	1146	976	1284	1116
# purchasing countries	8	50	75	77	79	88
NRTIs	4	40	57	66	63	57
NNRTIs	4	31	52	36	22	14
PIs	4	32	58	67	73	82
value (USD millions)	1.64	29.80	74.39	56.51	83.02	102.62